Patent Application
20230001223
The invention is related to electromagnetic stimulator and iontophoresis devices used for treating retina and optical nerve diseases.
The invention is particularly related to a personal electromagnetic stimulator and iontophoresis device which enables to reach the required threshold values for treating retina and optical nerve diseases with very low magnetic fields, which eliminates thermal damage risk formed at the cellular level by means of cooling cages, enables the transfer of ocular drug injections made to the retina using the electromagnetic iontophoresis method and allows usage by the patient alone at home, who has low vision, without receiving any professional help, thanks to the audio command guidance system.
Chronic retina and optical nerve diseases can be ischemic or degenerative. In degenerative diseases, the synthesis of the growth factors which enable vital functions of retina nerve cells are damaged genetically. In ischemic patients however, the blood flow and supply to retina nerve cells are damaged. In both cases, chronic and progressive visual loss is experienced and in the end legal blindness occurs.
The stimulation of the retina and optical nerve electromagnetically leads to retina blood flow increase at a cellular level, increase in vascular permeability and increase of receptor sensitivity in growth factors. Simultaneous stimulation of the occipital cortex leads to an increase in neurotrophic growth factor levels in the retina. The simultaneous electromagnetic stimulation of the retina, optical nerve, optical tracts and visual cortex leads to cellular depolarization and phosphene formation. In order for all of these effects to be realized a suprathreshold electromagnetic field is required. The required suprathreshold magnetic field can be obtained by the correct positioning of electromagnetic coils, correct frequency, power, intensity and time. These effects that are reparative in retina and optical nerve diseases must be applied at certain periods and times mostly for a lifelong period in chronic diseases. Due to this reason, in order to obtain an efficient result, the patient needs to use an electromagnetic stimulator on his/her own at home continuously and correctly.
In order for electromagnetic stimulation to be effective in retina and optical nerve diseases, the occipital cortex, inter-hemispherical sulcus, and the retina and optical nerves need to be stimulated at the same time. Retina and optical nerve stimulation is carried out from a vertex distance which is the most efficient distance. The vertex distance, is the closest distance to the cornea apex which does not prevent the closing of the eyelids. However the electromagnetic stimulator devices in the prior art, may cause thermal damage at a cellular level and therefore it is not possible to stimulate the eyeball, retina and optical nerve from the vertex distance. At the same time the devices of the prior art are suitable to be used under the supervision of a health personnel. The incorrect usage applied under the supervision of people who are not experts, may lead to many complications including visual loss. Some drug injections are applied in treating retina diseases. In order for these drugs to reach the retina, an iontophoresis procedure is required. In order for an iontophoresis procedure to be electromagnetically efficient the coils need to be effective simultaneously, in the same way, in the correct position and at the correct distance. In order to establish correct stimulation points and correct electrical polarization, the device needs to have a standard design. The present iontophoresis devices have effect not with an electromagnetic field but with an electric current. Electromagnetic iontophoresis is designed such that it does not contact the eye and therefore it is much safer than electrical iontophoresis devices.
The document numbered US2017165485 can be given as an example to the stimulator device in literature. In said document a device that has been developed to treat visual complaints during headaches and migraines is described. It is not possible to stimulate the eyeball, retina and optical nerves from the vertex distance with said device, it is possible to stimulate the supraorbital region at most with this device. It is not possible to reach effective suprathreshold values in the eye, during the treatment of retina and optical nerves with this device that is not indicated for treating degenerative and ischemic retina optical nerve diseases. The device does not have any cooling mechanism in order for the device to be used from the vertex distance. The device does not have a standard cap system placement design to the correct poles in order to perform electromagnetic iontophoresis. This design that has been defined with general terms according to requirements for placement of electromagnetic coils and electrodes does not have the required standard design in order to perform iontophoresis. This device does not comprise a design having the standard shape, number, distance and parameters that can apply an electromagnetic field at the vertex distance, and to establish standard poles between other electromagnetic coils.
Another example is the document numbered WO2009063435. Said document is related to a sensor system which shows if the coils have been placed in the correct position on the occipital cortex during amblyopia treatment. It is not indicated for being used in treating retina and optical nerve diseases. The device does not have any cooling mechanism in order for the device to be used from the vertex distance. The device does not have a standard cap system placement design to the correct poles in order to perform electromagnetic iontophoresis. Therefore said system is not designed to stimulate the eyeball, retina and optical nerves from the vertex distance.
Another example is the document numbered US2009099623. Said document is related to the treatment of medical conditions associated with the central nervous system and to increasing cognitive functions. The device does not have any cooling mechanism in order for the device to be used from the vertex distance. The device does not have a standard cap system placement design to the correct poles in order to perform electromagnetic iontophoresis. Said device is not designed or indicated for treating degenerative and ischemic retina optical nerve diseases.
Another example is the document numbered US2013137918. Said document is related to a low frequency magnetic stimulation treatment device. The device does not have any cooling mechanism in order for the device to be used from the vertex distance. The device does not have a standard cap system placement design to the correct poles in order to perform electromagnetic iontophoresis. Said device is not designed or indicated for treating degenerative and ischemic retina optical nerve diseases.
Another example is the document numbered GB2295093. Said document is related to a synchronized electromagnetic therapy device. The device does not have any cooling mechanism in order for the device to be used from the vertex distance. The device does not have a standard cap system placement design to the correct poles in order to perform electromagnetic iontophoresis. Said device is not designed or indicated for treating degenerative and ischemic retina optical nerve diseases.
As a result, the presence of the above mentioned problems and the inadequacy of the present solutions has made it a necessity to provide a development in the related technical field.
The present invention is related to a personal electromagnetic stimulator and iontophoresis device for treating retina and optical nerve diseases which eliminate the above mentioned disadvantages and bring about new advantages.
The aim of the invention is reach the required threshold values with very low magnetic fields in order to treat retina and optical nerve diseases by means of the cap worn by the patient, comprising electromagnetic coils that has a design which can be correctly positioned and which can stimulate the eyeball, retina and optical nerves directly.
The aim of the invention is to eliminate the risk of thermal damage at the cellular level as the electromagnetic coils are covered with cooling cages.
Another aim of the invention is to increase the passage of the ocular drug injections to the retina by means of the electromagnetic iontophoresis method as the electromagnetic coils are connected to the cap system such that it allows correct polarization.
Another aim of the invention is to prevent the formation of opacities in the cornea, lens and vitreous and to prevent permanent visual loss by eliminating thermal damage risk at the cellular level.
Another aim of the invention is to enable correct, safe and efficient usage of the stimulator device by the patient alone, without requiring professional assistance by means of the audio commands provided in different languages, to the patient having visual impairment.
Another aim of the invention is to notify the doctor following up the patient if the patient is using the device correctly or not, by means of the counter system on the device.
The invention is related to a stimulator and iontophoresis device used for treating retina and optical nerve diseases, in order to carry out all of the aims that can be construed from the information provided above and the detailed description below.
The invention is characterized in that it comprises;
The structural and characteristic features of the invention and all of its advantages can be better understood by means of the detailed description and by referring to the attached figures. Due to this reason, if an evaluation needs to be carried out, it must be done so by taking into consideration the attached figures and the detailed description.
In this detailed description the preferred embodiments of the stimulator and iontophoresis device (A) subject to the invention has been described only in order to better explain the subject matter and such that it does not create any kind of limiting effect.
The general view of the stimulator and iontophoresis device (A) subject to the invention has been provided in
As it can be seen from
The cap (10) comprises a total of 9 electromagnetic coil assemblies (12) that are fixedly embedded in order to reach the required threshold values with very low magnetic fields to treat retina and optical nerve diseases.
The front cap (10a) comprises 4 electromagnetic coil assemblies (12) that create electromagnetic fields at the vertex distance to the eyeballs and the rear cap (10b) comprises a total of 5 electromagnetic coil assemblies (12) that are in contact with the scalp wherein 4 electromagnetic fields stimulate the occipital cortex region and 1 electromagnetic field stimulates the inter-hemispheric region.
The sections besides the electromagnetic coil assembly (12) at the inner surfaces of the front cap (10a) and the rear cap (10b) are covered with a smart medical sponge rubber (13) that is non-inflammable, biocompatible, antiallergic and antibacterial. Said smart sponge rubber (13) enables the electromagnetic coil assemblies (12) to remain in the correct position during usage.
The electromagnetic coil assembly (12) illustrated in
LED indicators (1211) and magnetic field sensors (1222) are provided on each of the electromagnetic coils (121). Therefore the tracking of active and passive electromagnetic coils (121) have been enabled. The magnetic field sensors (1222) enable the transmission of the magnetic field formed, when the electromagnetic coil (121) is active onto the screen (24) of the electronic control box (20). As a result when the stimulator device (A) is active, by which electromagnetic coil (121) the amount of magnetic field is created and if this field is correct or not can be tracked during the duration of the treatment process.
The electromagnetic coils (121) receive their power from the power supply (27) in the electronic control box (20) to which it is connected via electrical cables (123). Said power supply (27) can be an adapter and/or battery-accumulator that operates directly with the electric network. If the stimulator and iontophoresis device (A) is operated with electricity, the battery-accumulator steps in order not to delay the treatment time and the battery-accumulator percentage can be seen on the screen (27).
In order to prevent thermal damage risk at the cellular level that may be encountered due to electromagnetic coils (121), a cooling cage (122) has been covered over each electromagnetic coil (121). The cooling cages (122) are made of fibreglass, fibre carbon or any kind of other medical material, formed as two layered hollow impermeable boxes. Each cooling cage (122) has a cooling tank (1221) which allows gas circulation therein, and a gas outlet hole (1222) and a gas inlet hole (1223) allowing the entrance and discharging of the cooling gas. The cooling compressor (22) in the electronic control box (20) and the elastic cooling pipes (124) extending from the gas perfluorocarbon tank (23) pass through each cooling cage (122) and allow the gas to be pumped into the cooling tank (1221) via the gas inlet hole (1222). The cooling gas exiting out of the cooling tank (1221) via the gas outlet hole (1223) cools the next cooling tank (1221) and then returns to the cooling compressor (22) and the cooling tank (1221) by recirculation.
The electric cables (123) connected to the electromagnetic coils (121) have been isolated below the cooling cage (122) and the cooling pipes (124) used in the cooling process is isolated under sponge rubber (13). Although said electric cables (123) and cooling pipes (124) pass through the connection rails (11), they are formed as an accordion such that they can be extended or shortened. This ensures adjustment ease for each head diameter.
As it can be seen in
In the case that the doctor following up the patient desires to conduct changes in the parameters with an aim besides performing electromagnetic iontophoresis, the technical staff can adjust the magnetic field intensity, frequency and time and which electromagnetic coil (121) needs to be passive-active. This adjustment is carried out by USB or WIRELESS connections or a password entered via the control panel (26) located inside the electronic control box (20).
By means of the counter (211) located on the electronic card and processor (21), the usage frequency of the stimulator device (A) by the patient and compatibility with treatment can be monitored by the doctor that is following up the patient.
The cooling compressor (20) and the gas perfluorocarbon tank (23) in the electronic control box (20) step in as soon as the stimulator device (A) creates an electromagnetic field and the electromagnetic coils (121) are cooled during the operation of the stimulator device (A) via the cooling cages (122) with +4° C. gas perfluorocarbon circulation. This cooling degree can be changed via the control panel (26) by the technical staff following the request of the doctor. The patient cannot control the cooling system and its temperature.
The electronic control box (20) is configured with a speaker (25) connected to an electronic card and processor (21), wherein said speaker (25) enables to guide the patient with audio commands in order for the patient who has visual impairment to be able to use the stimulator and iontophoresis device (A) alone, safely, correctly and efficiently. Thereby the audio guidance of the patient is provided with the speaker (25) following the detection by the magnetic field sensors (1212) connected to the electronic card and processor (21) that determine if the front cap (10a) is at a vertex distance to the eyeball or not, and if the electromagnetic coil assemblies (12) at the rear cap (10b) are at the correct contact distance symmetrically to the occipital cortex and inter-hemispheric regions. At the same time the starting of the treatment, ending of the treatment and remaining time are vocally notified to the patient via the speaker (25). Additionally by means of the electronic card and processor (21) the patient with low vision can be guided with commands in different languages.
The required parameters of the stimulator and iontophoresis device (A) for therapy, is efficient with various setting adjustments and is suitable for safe usage in order to prevent incorrect usage.
The magnetic field intensity at the electromagnetic coils (121), frequency, time and the electromagnetic coil (121) that is active, number of usages, and activation information of the stimulator and iontophoresis device (A) are collected via the counter (211) and such information can be seen on the screen (24) that is included in the electronic control box (20).
The electric cables (123) leading to the electromagnetic coil (121) and exiting out of the electronic control box (20) and the cooling pipes (124) between the cooling compressor (22) and the cooling cage (122) are housed as a group inside the connection pipe (30) that is positioned between the cap (10) and the electronic control box (20) such that they are insulated and isolated.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2019/18027 | Nov 2019 | TR | national |
This application is the national stage entry of International Application No. PCT/TR2019/000086, filed on Dec. 6, 2019, which is based upon and claims priority to Turkish Patent Application No. 2019/18027 filed on Nov. 19, 2019, the entire contents of which are incorporated herein by reference.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/TR2019/000086 | 12/6/2019 | WO |
